Basit öğe kaydını göster

Statistical Interpretation of CA125 and Bcl-2 in Serum of Patients With Late Stage Ovarian Cancer

dc.contributor.authorCamlica, Hakan
dc.contributor.authorTas, Faruk
dc.contributor.authorYasasever, Vildan
dc.contributor.authorDuranyildiz, Dery
dc.date.accessioned2021-03-05T13:07:13Z
dc.date.available2021-03-05T13:07:13Z
dc.date.issued2008
dc.identifier.citationCamlica H., Duranyildiz D., Tas F., Yasasever V., "Statistical Interpretation of CA125 and Bcl-2 in Serum of Patients With Late Stage Ovarian Cancer", AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, cilt.31, ss.585-588, 2008
dc.identifier.issn0277-3732
dc.identifier.otherav_b0a1af0d-bc66-41d6-828a-dde7735bc53f
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/117731
dc.identifier.urihttps://doi.org/10.1097/coc.0b013e318174dbd2
dc.description.abstractObjectives: The present study was conducted to investigate the sensitivity, specificity, predictive values and accuracy of serum CA 125 and Bcl-2 levels and their combination in advanced epithelial ovarian cancer patients.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectOnkoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleStatistical Interpretation of CA125 and Bcl-2 in Serum of Patients With Late Stage Ovarian Cancer
dc.typeMakale
dc.relation.journalAMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume31
dc.identifier.issue6
dc.identifier.startpage585
dc.identifier.endpage588
dc.contributor.firstauthorID7306


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster